IDEXX LABORATORIES Files 8-K on Financials
Ticker: IDXX · Form: 8-K · Filed: Feb 3, 2025 · CIK: 874716
| Field | Detail |
|---|---|
| Company | Idexx Laboratories Inc /De (IDXX) |
| Form Type | 8-K |
| Filed Date | Feb 3, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: IDXX
TL;DR
IDXX filed an 8-K for financial updates.
AI Summary
On February 3, 2025, IDEXX LABORATORIES, INC. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were disclosed in the provided excerpt.
Why It Matters
This 8-K filing indicates that IDEXX LABORATORIES is providing updates on its financial performance and condition to the SEC.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- IDEXX LABORATORIES, INC. (company) — Registrant
- February 3, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 000-19271 (filing_id) — Commission File Number
- 01-0393723 (tax_id) — IRS Employer Identification No.
- One IDEXX Drive, Westbrook, Maine 04092 (address) — Address of principal executive offices
- 207.556.0300 (phone) — Business phone number
FAQ
What specific financial information is being reported in this 8-K filing?
The provided excerpt states the filing concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail specific financial figures.
When was the earliest event reported in this filing?
The earliest event reported is dated February 3, 2025.
What is the principal executive office address for IDEXX LABORATORIES, INC.?
The principal executive office is located at One IDEXX Drive, Westbrook, Maine 04092.
In which state is IDEXX LABORATORIES, INC. incorporated?
IDEXX LABORATORIES, INC. is incorporated in Delaware.
What is the Commission File Number for IDEXX LABORATORIES, INC.?
The Commission File Number for IDEXX LABORATORIES, INC. is 000-19271.
Filing Stats: 567 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2025-02-03 06:30:47
Key Financial Figures
- $0.10 — ange on whichregistered Common Stock, $0.10 par value per share IDXX NASDAQ Glo
Filing Documents
- tm255269d1_8k.htm (8-K) — 35KB
- tm255269d1_ex99-1.htm (EX-99.1) — 536KB
- tm255269d1_8kimg01.jpg (GRAPHIC) — 4KB
- 0001104659-25-008331.txt ( ) — 789KB
- idxx-20250203.xsd (EX-101.SCH) — 3KB
- idxx-20250203_lab.xml (EX-101.LAB) — 33KB
- idxx-20250203_pre.xml (EX-101.PRE) — 22KB
- tm255269d1_8k_htm.xml (XML) — 3KB
02
Item 2.02 Results of Operations and Financial Condition. On February 3, 2025, IDEXX Laboratories, Inc. (the "Company") announced its financial results for the quarter and year ended December 31, 2024. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. In accordance with general instructions to Form 8-K, the information in this Form 8-K and the Exhibit 99.1 attached hereto is being furnished under Item 2.02 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed. Exhibit No. Description of Exhibit 99.1 Press Release entitled "IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results," issued by the Company on February 3, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IDEXX LABORATORIES, INC. Date: February 3, 2025 By: /s/ Brian P. McKeon Brian P. McKeon Executive Vice President, Chief Financial Officer and Treasurer 2